MetaVia MTVA
NASDAQ MTVA
$1.46 +0.02 (+1.39%)
At close: Aug 21, 2026 · 4:00 PM EDT

MetaVia (MTVA) Total Liabilities (2015 - 2026)

MetaVia's (MTVA) quarterly Total Liabilities came in at $5.8 million in Q4 2025, down 30.48% YoY from $8.3 million in Q4 2024, and down 31.35% on a QoQ basis from $8.4 million in Q3 2025.

MetaVia (MTVA) Total Liabilities (2015 - 2026) Analysis & Trends

MetaVia (MTVA) has 11 years of Total Liabilities data on file, last reported at $5.8 million in Q4 2025.

  • Quarterly Total Liabilities fell 30.48% year-over-year to $5.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $5.8 million (down 30.48% YoY) and the FY2025 annual result came in at $5.8 million, down 30.48% from the prior year.
  • Total Liabilities slipped to $5.8 million in Q4 2025, from $8.4 million in the prior quarter.
  • In the past five years, Total Liabilities ranged from a high of $11.8 million in Q4 2022 to a low of $1.0 million in Q1 2021.
  • A 5-year average of $5.7 million and a median of $5.9 million in 2023 frame the typical range for Total Liabilities.
  • Annual changes were most pronounced in 2021 — Total Liabilities plunged 73.41% — and 2023, when it soared 616.24%.
  • Tracing MTVA's Total Liabilities over 5 years: stood at $2.2 million in 2021, then surged by 435.15% to $11.8 million in 2022, then tumbled by 48.27% to $6.1 million in 2023, then soared by 36.63% to $8.3 million in 2024, then slumped by 30.48% to $5.8 million in 2025.
  • The last three Total Liabilities figures came in at $5.8 million (Q4 2025), $8.4 million (Q3 2025), and $8.8 million (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Liabilities (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 7.18 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 10.02 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 1.62 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 4.20 Bn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 4.00 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 4.20 Bn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 3.22 Bn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 1.35 Bn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 10.03 Bn
10 MetaVia 8.72 Mn -3.92 Mn - 6.45 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 6.45 Mn
Dec 31, 2025 5.79 Mn
Sep 30, 2025 8.43 Mn
Jun 30, 2025 8.84 Mn
Mar 31, 2025 7.75 Mn
Dec 31, 2024 8.33 Mn
Sep 30, 2024 9.19 Mn
Jun 30, 2024 9.81 Mn
Mar 31, 2024 6.94 Mn
Dec 31, 2023 6.10 Mn
Sep 30, 2023 4.88 Mn
Jun 30, 2023 3.98 Mn
Mar 31, 2023 10.98 Mn
Dec 31, 2022 11.78 Mn
Sep 30, 2022 1.62 Mn
Jun 30, 2022 1.25 Mn
Mar 31, 2022 1.53 Mn
Dec 31, 2021 2.20 Mn
Sep 30, 2021 1.95 Mn
Jun 30, 2021 1.24 Mn